*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter - as a primary diagnosis code | T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 6.48 | |
Readmission Rate (%) | 26.03 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 71,748 | |
Total Hospitalizations with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 54 | |
DRG Share of Total Hospitalizations | 0.22 | |
% of Total ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter in DRG | 50.47 | |
Avg LOS at DRG | 2.93 | |
Avg LOS with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 3.46 | |
Readmission Rate at DRG | 33.86 | |
Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | |
Unplanned Readmission Rate at DRG | 10.34 | |
Unplanned Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | |
Total Medicare payments at DRG | $313,351,773 | |
Total Medicare payments with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $261,774 | |
Total Medicare payment per Day at DRG | $1,489 | |
Total Medicare payment per Day with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $1,400 | |
Total Medicare payment per Hospitalization at DRG | $4,367 | |
Total Medicare payment per Hospitalization with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $4,848 | |
Total Medicare Charges at DRG | $1,750,048,705 | |
Total Medicare Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $1,392,865 | |
Avg Charges at DRG | $24,392 | |
Avg Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $25,794 | |
Mortality Rate at DRG | 0.22 | |
Mortality Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | |
SNF Discharge Rate at DRG | 7.61 | |
SNF Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | |
Home Discharge Rate at DRG | 51.88 | |
Home Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 55.56 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 292,335 | ||||
Total Hospitalizations with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 2,315 | ||||
DRG Share of Total Hospitalizations | 0.89 | ||||
% of Total ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter in DRG | 8.9 | ||||
Avg LOS at DRG | 2.96 | ||||
Avg LOS with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 3.34 | ||||
Readmission Rate at DRG | 19.18 | ||||
Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 20.13 | ||||
Unplanned Readmission Rate at DRG | 13.96 | ||||
Unplanned Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 15.13 | ||||
Total Medicare payments at DRG | $1,347,436,356 | ||||
Total Medicare payments with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $11,008,934 | ||||
Total Medicare payment per Day at DRG | $1,557 | ||||
Total Medicare payment per Day with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $1,425 | ||||
Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
Total Medicare payment per Hospitalization with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $4,755 | ||||
Total Medicare Charges at DRG | $7,385,462,160 | ||||
Total Medicare Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $62,640,510 | ||||
Avg Charges at DRG | $25,264 | ||||
Avg Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $27,059 | ||||
Mortality Rate at DRG | 0.57 | ||||
Mortality Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 11.55 | ||||
SNF Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 11.92 | ||||
Home Discharge Rate at DRG | 63.79 | ||||
Home Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 64.19 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 422,757 | ||||
Total Hospitalizations with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 753 | ||||
DRG Share of Total Hospitalizations | 1.29 | ||||
% of Total ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter in DRG | 2.9 | ||||
Avg LOS at DRG | 4.14 | ||||
Avg LOS with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 4.64 | ||||
Readmission Rate at DRG | 24.43 | ||||
Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 25.9 | ||||
Unplanned Readmission Rate at DRG | 18.48 | ||||
Unplanned Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 18.87 | ||||
Total Medicare payments at DRG | $2,636,135,714 | ||||
Total Medicare payments with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $4,794,379 | ||||
Total Medicare payment per Day at DRG | $1,507 | ||||
Total Medicare payment per Day with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $1,373 | ||||
Total Medicare payment per Hospitalization at DRG | $6,236 | ||||
Total Medicare payment per Hospitalization with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $6,367 | ||||
Total Medicare Charges at DRG | $11,980,955,733 | ||||
Total Medicare Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $24,423,455 | ||||
Avg Charges at DRG | $28,340 | ||||
Avg Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $32,435 | ||||
Mortality Rate at DRG | 1.01 | ||||
Mortality Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 16.05 | ||||
SNF Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 14.61 | ||||
Home Discharge Rate at DRG | 47.18 | ||||
Home Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 51.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 205: OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 434,264 | ||||
Total Hospitalizations with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 410 | ||||
DRG Share of Total Hospitalizations | 1.32 | ||||
% of Total ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter in DRG | 1.58 | ||||
Avg LOS at DRG | 3.94 | ||||
Avg LOS with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 4.13 | ||||
Readmission Rate at DRG | 22.76 | ||||
Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 26.23 | ||||
Unplanned Readmission Rate at DRG | 16.46 | ||||
Unplanned Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 17.4 | ||||
Total Medicare payments at DRG | $2,472,138,198 | ||||
Total Medicare payments with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $2,377,339 | ||||
Total Medicare payment per Day at DRG | $1,444 | ||||
Total Medicare payment per Day with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $1,404 | ||||
Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
Total Medicare payment per Hospitalization with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $5,798 | ||||
Total Medicare Charges at DRG | $12,478,361,060 | ||||
Total Medicare Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $12,279,619 | ||||
Avg Charges at DRG | $28,735 | ||||
Avg Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $29,950 | ||||
Mortality Rate at DRG | 0.91 | ||||
Mortality Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 22.02 | ||||
SNF Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 20.98 | ||||
Home Discharge Rate at DRG | 46.68 | ||||
Home Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 44.39 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 55,775 | ||||
Total Hospitalizations with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 294 | ||||
DRG Share of Total Hospitalizations | 0.17 | ||||
% of Total ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter in DRG | 1.13 | ||||
Avg LOS at DRG | 6.91 | ||||
Avg LOS with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 8.19 | ||||
Readmission Rate at DRG | 23.54 | ||||
Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 27.6 | ||||
Unplanned Readmission Rate at DRG | 14.61 | ||||
Unplanned Readmission Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 19.35 | ||||
Total Medicare payments at DRG | $1,347,495,990 | ||||
Total Medicare payments with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $7,054,487 | ||||
Total Medicare payment per Day at DRG | $3,498 | ||||
Total Medicare payment per Day with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $2,931 | ||||
Total Medicare payment per Hospitalization at DRG | $24,159 | ||||
Total Medicare payment per Hospitalization with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $23,995 | ||||
Total Medicare Charges at DRG | $6,626,803,325 | ||||
Total Medicare Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $35,454,218 | ||||
Avg Charges at DRG | $118,813 | ||||
Avg Charges with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | $120,593 | ||||
Mortality Rate at DRG | 2.32 | ||||
Mortality Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 27.28 | ||||
SNF Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 31.63 | ||||
Home Discharge Rate at DRG | 38.04 | ||||
Home Discharge Rate with ICD T462X5A - Adverse effect of other antidysrhythmic drugs, initial encounter | 35.03 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
CLEVELAND CLINIC | 9500 EUCLID AVE | CLEVELAND | OH | 44195 | 141 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 130 |
CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 92 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. ALAIN L. HEROUX | 2160 S 1ST AVE | MAYWOOD | IL | 60153 | 16 |
Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 11 |
Dr. SANDEEP CHAPALAMADUGU RAO | 1239 STAR ST | PERRYVILLE | MO | 63775 | 11 |